トップ ( Japanese / English )  お問い合わせ  サイトマップ
教室について
論文一覧
英文
YEAR TITLE & JOURNAL/AUTHORS
2016
Absence of cytoglobin promotes multiple organ abnormalities in aged mice.
著書名: Thuy le TT, Van Thuy TT, Matsumoto Y, Hai H, Ikura Y, Yoshizato K, Kawada N.
出版物名: Scientific Reports. 2016 May 5;6:24990.
  Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
著書名: Matsunami K, Nishida N, Kaneko N, Ikeo K, Toyo-Oka L, Takeuchi H, Matsuura K, Tamori A, Nomura H, Yoshiji H, Imamura M, Masaki N, Hayakawa T, Ide T, Shimada N, Ikeda F, Hino K, Nishiguchi S, Okuse C, Nojiri S, Sawamoto K, Tokunaga K, Joh T, Tanaka Y.
出版物名: PLoS One. 2016 Oct 10;11(10):e0164418. doi: 10.1371/journal.pone.0164418.
  Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
著書名: Nojima M, Matsui T, Tamori A, Kubo S, Shirabe K, Kimura K, Shimada M, Utsunomiya T, Kondo Y, Lio E, Naito Y, Ochiya T, Tanaka Y.
出版物名: Mol Cancer. 2016 Apr 30;15(1):31. doi: 10.1186/s12943-016-0514-6.
  Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis.
著書名: Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H, Yokosuka O, Koike K, Kurosaki M, Izumi N, Korenaga M, Kang JH, Tanaka E, Taketomi A, Eguchi Y, Sakamoto N, Yamamoto K, Tamori A, Sakaida I, Hige S, Itoh Y, Mochida S, Mita E, Takikawa Y, Ide T, Hiasa Y, Kojima H, Yamamoto K, Nakamura M, Saji H, Sasazuki T, Kanto T, Tokunaga K, Mizokami M.
出版物名: Sci Rep. 2016 Apr 19;6:24767. doi: 10.1038/srep24767.
  Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with HCV genotype 1b.
著書名: Tamori A, Yoshida K, Kurai O, Kioka K, Hai H, Kozuka R, Motoyama H, Kawamura E, Hagihara A, Uchida-Kobayashi S, Morikawa H, Enomoto M, Murakami Y, Kawada N.
出版物名: Hepatol Res. 2016 Mar 2.
  Pathophysiological role of cytoglobin, the fourth globin in mammals, in liver diseases.
著書名: Thuy Le TT, Nguyen Hai TT, Hai H, Kawada N.
出版物名: Histol Histopathol. 2016; 31(3): 257-267.
  Outcomes of laparoscopic hepatic resection versus percutaneous radiofrequency ablation for hepatocellular carcinoma located at the liver surface: A case-control study with propensity score matching.
著書名: Ito T, Tanaka S, Iwai S, Takemura S, Hagihara A, Uchida-Kobayashi S, Shinkawa H, Nishioka T, Kawada N, Kubo S.
出版物名: Hepatol Res. 2016 May;46(6):565-74.
  Putting "sticky notes" on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study.
著書名: Fujii H, Yamaguchi S, Kurai O, Miyano M, Ueda W, Oba H, Aoki T, Enomoto M, Kawada N, Okawa K.
出版物名: BMC Infect Dis. 2016 Aug 12;16:410. doi: 10.1186/s12879-016-1765-y.
  The Alcohol Use Disorders Identification Test for Consumption (AUDIT-C) is more useful than pre-existing laboratory tests for predicting hazardous drinking: a cross-sectional study.
著書名: Fujii H, Nishimoto N, Yamaguchi S, Kurai O, Miyano M, Ueda W, Oba H, Aoki T, Kawada N, Okawa K.
出版物名: BMC Public Health. 2016 May 10;16:379. doi: 10.1186/s12889-016-3053-6.
  Prediction for Improvement of Liver Function after Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices to Manage Portosystemic Shunt Syndrome.
著書名: Yamamoto A, Nishida N, Morikawa H, Jogo A, Kageyama K, Sohgawa E, Hamamoto S, Takeshita T, Sakai Y, Matsuoka T, Kawada N, Miki Y.
出版物名: J Vasc Interv Radiol.2016 Aug;27(8):1160-7.
  Basic investigation on acoustic velocity change imaging method for quantitative assessment of fat content in human liver.
著書名: Kazune Mano, Shohei Tanigawa, Makoto Hori, Daiki Yokota, Kenji Wada,Toshiyuki Matsunaka, Hiroyasu Morikawa, and Hiromichi Horinaka.
出版物名: Japanese Journal of Applied Physics 55, 07KF20 (2016)
  Development of non-invasive method for assessment of hepatic steatosis.
著書名: Morikawa H, Mano K, Horinaka H, Matsunaka T, Matsumoto Y, Ida T, Kawaguchi Y, Wada K, Kawada N.
出版物名: Ultrasonics. 2016 Dec;72:195-200.
  Development of ultrasound-assisted fluorescence imaging of indocyanine green.
著書名: Morikawa H, Toyota S, Wada K, Uchida-Kobayashi S, Kawada N, Horinaka H.
出版物名: J Med Ultrason (2001). 2016 Aug 26.
  Molecular dynamics simulations to determine the structure and dynamics of hepatitis B virus capsid bound to a novel anti-viral drug.
著書名: Watanabe G, Sato S, Iwadate M, Umeyama H, Hayakawa M, Murakami Y, Yoneda S.
出版物名: Chem. Pharm. Bull.2016;64(9):1393-6.
  MiR-29a assists in preventing the activation of human stellate cells and promotes recovery from liver fibrosis in mice.
著書名: Matsumoto Y, Itami S, Kuroda M, Yoshizato K, Kawada N, Murakami Y.
出版物名: Mol Ther. 2016 Oct;24(10):1848-1859. doi: 10.1038/mt.2016.127
  Different Variants in Reverse Transcriptase Domain Determined by Ultra-deep Sequencing in Treatment-naive and Treated Indonesian Patients Infected with Hepatitis B Virus.
著書名: Wasityastuti W, Yano Y, Widasari DI, Yamani LN, Ratnasari N, Heriyanto DS, Okada R, Tanahashi T, Murakami Y, Azuma T, Hayashi Y.
出版物名: Kobe J Med Sci. 2016 Jun 16;62(1):E1-8.
  MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy.
著書名: Tamori A, Murakami Y, Shoji K, Itami S, Uchida-Kobayashi S, Morikawa H, Enomoto M, Takemura S, Tanahashi, T, Y-h Taguchi, Kawada N.
出版物名: Hepatol Res. 2016 Mar;46(3):E26-35.
  Pathophysiological role of cytoglobin, the fourth globin in mammals, in liver diseases.
著書名: Thuy le TT, Hai NT, Hai H, Kawada N.
出版物名: Histol Histopathol. 2016; 31:257-267.
  Basic and Clinical Advances in Chronic Liver Inflammation.
著書名: Enomoto H, Tamori A, Yoshiji H, Seki E.
出版物名: Mediators Inflamm. 2016; 1571457. doi: 10.1155/2016/1571457
  Principal component analysis based unsupervised feature extraction applied to bioinformatics analysis, in "Computational methods with applications in bioinformatics analysis" 2016 eds. Jing-Pha Tsai and Ka-Lok Ng.
著書名: Taguchi Y-h, Iwadate M, Umeyama H, Murakami Y.
出版物名: Imperial College Press, in press.
  MicroRNAs in hepatic pathophysiology.
著書名: Murakami Y and Kawada N.
出版物名: Hepatol Res. 2016 Apr 21. doi: 10.1111/hepr.12730
  Role of Oxidative and Nitrosative Stress in Hepatic Fibrosis.
著書名: Le Thi Thanh Thuy, Tuong Thi Van Thuy, Hoang Hai, and Norifumi Kawada.
出版物名: Liver Pathophysiology: Therapies and Antioxidants. Chapter 17. Elsevier publishing group. 2016
  Recent advances in antiviral therapy for chronic hepatitis C.
著書名: Tamori A, Enomoto M, Kawada N.
出版物名: Mediators of Inflammation 2016.:6841628.doi:10.1155/2016/6841628
  New player in tumor-stromal interaction: Granulin as a novel therapeutic target for pancreatic ductal adenocarcinoma liver metastasis.
著書名: Sato-Matsubara M, Kawada N.
出版物名: 2016 Sep 19. doi: 10.1002/hep.28849.
YEAR TITLE & JOURNAL/AUTHORS
2015
Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts
Kawada, Norifumi
FRONTIERS IN PHYSIOLOGY 巻: 6 記事番号: 329 発行: NOV 13 2015
 
Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
Murakami, Yoshiki; Kubo, Shoji; Tamori, Akihiro; et al.
SCIENTIFIC REPORTS 巻: 5 記事番号: 16294 発行: NOV 5 2015
 
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers
Kamada Y, Ono M, Hyogo H, Fujii H, Sumida Y, Mori K, Tanaka S, Yamada M, Akita M, Mizutani K, Fujii H, Yamamoto A, Takamatsu S, Yoshida Y, Itoh Y, Kawada N, Chayama K, Saibara T, Takehara T, Miyoshi E.
HEPATOLOGY 巻: 62 号: 5 ページ: 1433-1443 発行: NOV 2015
 
Transient Elastography-Based Liver Profiles in a Hospital-Based Pediatric Population in Japan
Cho, Yuki; Tokuhara, Daisuke; Morikawa, Hiroyasu; et al.
PLOS ONE 巻: 10 号: 9 記事番号: e0137239 発行: SEP 23 2015
 
Development of novel hepatitis B virus capsid inhibitor using in silico screening
Hayakawa, Michiyo; Umeyama, Hideaki; Iwadate, Mitsuo; et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 巻: 463 号: 4 ページ: 1165-1175 発行: AUG 7 2015
 
Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-beta in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection
Enomoto, Masaru; Nishiguchi, Shuhei; Tamori, Akihiro; et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 巻: 35 号: 8 ページ: 613-620 発行: AUG 1 2015
 
Interferon-beta Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model
Shimozono Rieko, Nishimura Kazumi, Akiyama Hideo, Funamoto Saeko, Izawa Akiko, Sai Takafumi, Kunita Kana, Kainoh Mie, Suzuki Tomohiko, and Kawada Norifumi.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 巻: 35 号: 6 ページ: 464-473 発行: JUN 1 2015
 
Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism
Teranishi, Yuga; Matsubara, Tsutomu; Krausz, Kristopher W.; et al.
LABORATORY INVESTIGATION 巻: 95 号: 5 ページ: 515-524 発行: MAY 2015
 
Cytoglobin Deficiency Promotes Liver Cancer Development from Hepatosteatosis through Activation of the Oxidative Stress Pathway
Le Thi Thanh Thuy; Matsumoto, Yoshinari; Tuong Thi Van Thuy; et al.
AMERICAN JOURNAL OF PATHOLOGY 巻: 185 号: 4 ページ: 1045-1060 発行: APR 2015
 
Discovering novel direct acting antiviral agents for HBV using in silico screening
Murakami, Yoshiki; Hayakawa, Michiyo; Yano, Yoshihiko; et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 巻: 456 号: 1 ページ: 20-28 発行: JAN 2 2015
 
Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C
Iio E, Matsuura K, Nishida N, Maekawa S, Enomoto N, Nakagawa M, Sakamoto N, Yatsuhashi H, Kurosaki M, Izumi N, Hiasa Y, Masaki N, Ide T, Hino K, Tamori A, Honda M, Kaneko S, Mochida S, Nomura H, Nishiguchi S, Okuse C, Itoh Y, Yoshiji H, Sakaida I, Yamamoto K, Watanabe H, Hige S, Matsumoto A, Tanaka E, Tokunaga K, Tanaka Y.
HUMAN GENETICS 巻: 134 号: 3 ページ: 279-289 発行: MAR 2015
 
Effects on anemia of drug adjustment in patients with chronic hepatitis C during telaprevir-combined therapy
Tamori, Akihiro; Kioka, Kiyohide; Sakaguchi, Hiroki; et al.
ANNALS OF HEPATOLOGY 巻: 14 号: 1 ページ: 28-35 発行: JAN-FEB 2015
 
Ultra-deep Sequencing to Detect Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients.
Yamani L, Murakami Y, Azuma T, Soetjipto S, Lusida M, and Hayashi Y. Journal of Clinical
Microbiology. 2015 Oct;53(10):3165-75. doi: 10.1128/JCM.00602-15. Epub 2015 Jul 22.
 
MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy.
著者名Tamori A, Murakami Y.
Hepatology Res 2015 Mar 18. doi: 10.1111/hepr.12518
 
Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.
著者名Horibe S, Murakami Y.
Life Science 2015 Mar 1;124:31-40. doi: 10.1016/j.lfs.2015.01.011. Epub 2015 Jan 24.
 
Control of HCV replication with iMIRs, a novel anti-RNAi agent.
Itami S, Murakami Y.
Molecular Therapy-Nucleic Acids 2015 2015 Jan; 4(1): e219.Published online 2015 Jan 20. doi: 10.1038/mtna.2014.71
YEAR TITLE & JOURNAL/AUTHORS
2014
Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy.
著書名:Nishikawa H, Enomoto H, Nasu A, Aizawa N, Saito M, Tamori A, Kawada N, Kimura T, Osaki Y, Nishiguchi S.
出版物名:Hepatol Res. 2014Dec;44(14):E397-E407. doi: 10.1111/hepr.12326. Epub 2014 May 6. PubMed PMID:24628684.
  Noninvasive diagnosis of liver fibrosis: utility of data mining of both ultrasound elastography and serological findings to construct a decision tree.
著書名:Yada N, Kudo M, Kawada N, Sato S, Osaki Y, Ishikawa A, Miyoshi H, Sakamoto M, Kage M, Nakashima O, Tonomura A.
出版物名:Oncology. 2014;87 Suppl 1:63-72. doi: 10.1159/000368147. Epub 2014 Nov 22.
  Murine Herc6 plays a critical role in protein ISGylation in vivo and has an ISGylation independent function in seminal vesicles.
著書名:Arimoto K, Hishiki T, Kiyonari H, Abe T, Cheng C, Yan M, Fan J, Futakuchi M, Tsuda H, Murakami Y, Suzuki H, Zhang D, Shimotohno K.
出版物名:J Interferon Cytokine Res. 2014 Nov 19. [Epub ahead of print]
  A Deep-Sequencing Method Detects Drug-Resistant Mutations in the Hepatitis B Virus in Indonesians.
著書名:Widasari DI, Yano Y, Heriyanto DS, Utsumi T, Yamani LN, Rinonce HT, Wasityastuti W, Lusida MI, Soetjipto, Okada R, Murakami Y, Tanahashi T, Azuma T, Hayashi Y.
出版物名:Intervirology. 2014;57(6):384-92. doi: 10.1159/000366420. Epub 2014 Oct 31.
  Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.
著書名:Enomoto M, Morikawa H, Tamori A, Kawada N.
出版物名:World J Gastroenterol. 2014 Sep 14;20(34):12031-8. doi: 10.3748/wjg.v20.i34.12031. PubMed PMID: 25232240; PubMed
Central PMCID: PMC4161791.
  Comparison of hepatocellular carcinoma miRNA expression profiling as evaluated by next generation sequencing and microarray.
著書名:Murakami Y, Tanahashi T, Okada R, Toyoda H, Kumada T, Enomoto M, Tamori A,Kawada N, Taguchi YH, Azuma T.
出版物名:PLoS One. 2014 Sep 12;9(9):e106314. doi: 10.1371/journal.pone.0106314.
eCollection 2014. PubMed PMID: 25215888; PubMed Central PMCID: PMC4162537.
  Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.
著書名:Kawamura E, Shiomi S, Kotani K, Kawabe J, Hagihara A, Fujii H,
Uchida-Kobayashi S, Iwai S, Morikawa H, Enomoto M, Murakami Y, Tamori A, Kawada
出版物名:J Gastroenterol Hepatol.2014 Sep;29(9):1722-7. doi: 10.1111/jgh.12611. PubMed PMID: 24730671.
  Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy.
著書名:Tamori A, Hino M, Kawamura E, Fujii H, Uchida-Kobayashi S, Morikawa H, Nakamae H, Enomoto M, Murakami Y, Kawada N.
出版物名:J Gastroenterol Hepatol. 2014 Sep;29(9):1715-21. doi:10.1111/jgh.12604. PubMed PMID: 24730465.
  Successful Treatment of Hepatitis B Virus-associated Membranous Nephro- pathy with Entecavir and Immunosuppressive Agents. 
著書名:Ochi A, Ishimura E, Ichii M, Ohno Y, Nakatani S, Kobayashi I, Shima H, Tsuda A, Shidara K, Mori K, Tamori A, Inaba M.
出版物名:Nephrology (Carlton). 2014 Sep;19(9):595-6. doi: 10.1111/nep.12292.
  Universal disease biomarker: can a fixed set of blood microRNAs diagnose multiple diseases?
著書名:Taguchi Y-h and Murakami Y.
出版物名:BMC Res Notes. 2014 Aug 30;7:581. doi: 10.1186/1756-0500-7-581.
  Fibrogenesis in alcoholic liver disease
著者名: Fujii, Hideki; Kawada, Norifumi
WORLD JOURNAL OF GASTROENTEROLOGY 巻: 20 号: 25 ページ: 8048-8054
発行: JUL 7 2014
  Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan
著著書名:Shoji Kubo, Yasuni Nakanuma, Shigekazu Takemura, Chikaharu Sakata, Yorihisa Urata, Akinori Nozawa, Takayoshi Nishioka, Masahiko Kinoshita, Genya Hamano, Hiroaki Terajima, Gorou Tachiyama, Yuji Matsumura, Terumasa Yamada, Hiromu Tanaka, Shoji Nakamori, Akira Arimoto, Norifumi Kawada, Masahiro Fujikawa, Hiromitsu Fujishima, Yasuhiko Sugawara, Shogo Tanaka, Hideyoshi Toyokawa, Yuko Kuwae, Masahiko Ohsawa, Shinichiro Uehara, Kyoko Kogawa Sato, Tomoshige Hayashi, Ginji Endo
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 巻: 21 号: 7 ページ: 479-88
発行: JUL 2014
  Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes.
著書名:Iwamoto A, Tanahashi T, Okada R, Yoshida Y, Kikuchi K, Keida Y, Murakami Y, Yang L, Yamamoto K, Nishiumi S, Yoshida Y and Azuma T.
出版物名:Gut Pathogens 2014 Jun 26;6:27.
  Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection
著者名: Kumada, Hiromitsu; Suzuki, Yoshiyuki; Ikeda, Kenji; et al.
出版物名:Hepatology. 2014 Jun;59(6):2083-91. doi: 10.1002/hep.27113. Epub 2014 Apr 1.
  Influenza A (H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients.
著書名:Ohfuji S, Fukushima W, Tamori A, Kurai O, Kioka K, Maeda K, Maeda A, Hirota Y.
出版物名:Liver Int. 2014 May;34(5):700-6. doi: 10.1111/liv.12295. Epub 2013 Aug 28.
  Role of hepatitis B virus DNA integration in human hepatocarcinogenesis.
著書名:Hai H, Tamori A, Kawada N.
出版物名:World J Gastroenterol. 2014 May 28;20(20):6236-43. doi: 10.3748/wjg.v20.i20.6236.
PubMed PMID: 24876744; PubMed Central PMCID: PMC4033461.
  Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver.
著書名:Motoyama H, Komiya T, Thuy le TT, Tamori A, Enomoto M, Morikawa H, Iwai S,Uchida-Kobayashi S, Fujii H, Hagihara A, Kawamura E, Murakami Y, Yoshizato K,Kawada N.
出版物名:Lab Invest. 2014Feb;94(2):192-207. doi: 10.1038/labinvest.2013.135.
Epub 2013 Dec 2. PubMed PMID:24296877.
  New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia.
著書名:Nishida N, Sawai H, Kashiwase K, Minami M, Sugiyama M, Seto WK, Yuen MF, Posuwan N, Poovorawan Y, Ahn SH, Han KH, Matsuura K, Tanaka Y, Kurosaki M, Asahina Y, Izumi N, Kang JH, Hige S, Ide T, Yamamoto K, Sakaida I, Murawaki Y, Itoh Y, Tamori A, Orito E, Hiasa Y, Honda M, Kaneko S, Mita E, Suzuki K, Hino K, Tanaka E, Mochida S, Watanabe M, Eguchi Y, Masaki N, Murata K, Korenaga M, Mawatari Y, Ohashi J, Kawashima M, Tokunaga K, Mizokami M.
出版物名:PLoS One. 2014 Feb 10;9(2):e86449. doi: 10.1371/journal.pone.0086449. eCollection 2014.
  Virologic escape in HCV genotype 1-infected patients receiving daclatasvir plus ribavirin and peginterferon alfa-2a or alfa-2b
著書名:Fiona McPhee, Dennis Hernandez, Nannan Zhou, Fei Yu, Joseph Ueland, Aaron Monikowski, Kazuaki Chayama, Joji Toyota, Namiki Izumi, Osamu Yokosuka, Norifumi Kawada, Yukio Osaki, Eric A Hughes, Hideaki Watanabe, Hiroki Ishikawa, Hiromitsu Kumada
出版物名: Antivir Ther. 2014;19(5):479-90. doi: 10.3851/IMP2729. Epub 2014 Jan 22.
  Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1
著書名:Namiki Izumi, Osamu Yokosuka, Norifumi Kawada, Yukio Osaki, Kazuhide Yamamoto, Michio Sata, Hiroki Ishikawa, Tomoko Ueki, Wenhua Hu, Fiona McPhee, Eric A Hughes, Hiromitsu Kumada
出版物名:Antivir Ther. 2014;19(5):501-10. doi: 10.3851/IMP2731. Epub 2014 Jan 22.
  A phase I study of sorafenib combined with transcatheter arterial infusion of cisplatin for advanced hepatocellular carcinoma.
著者名:Atsushi Hagihara, Masafumi Ikeda, Takuji Okusaka, et al.
出版物名:Cancer Science 2014 in press
  Relationship between inosine triphosphate genotype and outcome of extended therapy in hepatitis C virus patients with a late viral response to pegylated-interferon and ribavirin. J
著書名:Hai H, Tamori A, Enomoto M, Morikawa H, Uchida-Kobayashi S, Fujii H, Hagihara A, Kawamura E, Thuy le TT, Tanaka Y, Kawada N.
出版物名: J Gastroenterol Hepatol. 2014 Jan;29(1):201-7. doi: 10.1111/jgh.12376.
PubMed PMID:23980585.発行:2014 Jan
  Impact of HBV Integration into Liver Tissue on the Efficacy of Peginterferon and Ribavirin Therapy in HBV-Negative Chronic Hepatitis C Patients
著書名:Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Yamamoto K, Murakami Y.
出版物名:J Clin Gastroenterol. 2014 Jan;48(1):73-9. doi: 10.1097/MCG.0b013e31829c409d.
YEAR TITLE & JOURNAL/AUTHORS
2013
Real-time PCR assays for hepatitis C virus RNA (genotype1) is useful for evaluating virological response to the treatment with peginterferon-alpha2b and ribavirin.
著書名:Nakaya M, Enomoto M, Fujii H, Kobayashi S, Iwai S, Morikawa H, Tamori A,
Sakaguchi H, Kawada N.
出版物名:Osaka City Med J. 2013 Dec;59(2):79-89.PubMed PMID: 24575583.
  Interferon-α/β for treatment of chronic hepatitis C infection in the era of direct-acting antiviral agents.
著書名: Enomoto M, Tamori A, Murakami Y, Kawada N.
出版物名: Hepatol Res.. doi: 10.1111/hepr.12289. [Epub ahead of print] PubMed PMID: 24330005.発行: 2013 Dec 11
  Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver.
著書名: Motoyama H, Komiya T, Thuy LT, Tamori A, Enomoto M, Morikawa H, Iwai S, Uchida-Kobayashi S, Fujii H, Hagihara A, Kawamura E, Murakami Y, Yoshizato K, Kawada N.
出版物名: Lab Invest. doi:10.1038/labinvest.2013.135. [Epub ahead of print] PubMed PMID: 24296877.発行:2013 Dec 2.
  Effect of caffeine-containing beverage consumption on serum alanine aminotransferase levels in patients with chronic hepatitis C virus infection: a hospital-based cohort study.
著書名: Sasaki Y, Ohfuji S, Fukushima W, Tamori A, Enomoto M, Habu D, Iwai S, Uchida-Kobayashi S, Fujii H, Shiomi S, Kawada N, Hirota Y.
出版物名: PLoS One. 11;8(12):e83382. doi: 10.1371/journal.pone.0083382.PubMed PMID: 24349501; PubMed Central PMCID: PMC3859663. 発行:2013 Dec
  Adjuvant epoetin-β with peginterferon-α and ribavirin in Japanese ribavirin-intolerant relapsed patients with chronic hepatitis C genotype 2. 4
著書名:
Enomoto M, Morikawa H, Murakami Y, Tamori A, Kawada N.
出版物名: Hepatol Res. doi:10.1111/hepr.12257. [Epub ahead of print] PubMed PMID: 24119110.発行:2013 Oct 11
  Branched-chain Amino Acids Prevent Hepatocarcinogenesis and Prolong Survival of Patients With Cirrhosis.
著書名:Kawaguchi T, Shiraishi K, Ito T, Suzuki K, Koreeda C, Ohtake T, Iwasa M, Tokumoto Y, Endo R, Kawamura NH, Shiraki M, Habu D, Tsuruta S, Miwa Y, Kawaguchi A, Kakuma T, Sakai H, Kawada N, Hanai T, Takahashi SI, Kato A, Onji M, Takei Y, Kohgo Y, Seki T, Tamano M, Katayama K, Mine T, Sata M, Moriwaki H, Suzuki K.
出版物名: Clin Gastroenterol Hepatol.. pii: S1542-3565(13)01312-8. doi: 10.1016/j.cgh.2013.08.050. [Epub ahead of print] PubMed PMID: 24036055. 発行: 2013 Sep 10
  HLA class II associated with outcomes of hepatitis B and C infections
著者名: Tamori, A (Tamori, Akihiro)[ 1 ] ; Kawada, N (Kawada, Norifumi)[ 1 ]
出版物名: WORLD JOURNAL OF GASTROENTEROLOGY 巻: 19 号: 33 ページ: 5395-5401 DOI: 10.3748/wjg.v19.i33.5395 発行:SEP 7 2013
  Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients.
著者名:Ohfuji S, Fukushima W, Sasaki Y, Tamori A, Kurai O, Kioka K, Maeda K, Maeda A, Hirota Y.
出版物名:Liver Int. doi: 10.1111/liv.12295. [Epub ahead of print] PMID: 23981146発行:2013 Aug 2.
Association between Hepatic Steatosis and Hepatic Expression of Genes Involved in Innate Immunity in Patients with Chronic Hepatitis C.
Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Kitabatake S, Murakami Y. Cytokine 2013 Aug;63(2):145-50.
Cytokine 2013 Aug;63(2):145-50.
  A Complete Response Induced by 21-day Sorafenib Therapy in a Patient with Advanced Hepatocellular Carcinoma.
著書名:Hagihara A, Teranishi Y, Kawamura E, Fujii H, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N.
出版物名: Intern Med. 2013;52(14):1589-92. Epub. PubMed PMID: 23857091.発行:2013 Jul 15
  Impact of HBV Integration into Liver Tissue on the Efficacy of Peginterferon and Ribavirin Therapy in HBV-Negative Chronic Hepatitis C Patients
著者名: Hidenori Toyoda , Takashi Kumada , S Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, Toshifumi Tada, K Yamamoto, Yoshiki Murakami.
出版物名: J Clin Gastroenterol. PMID: 23842217 発行:2013 Jul 8.
  Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.
Kamada Y, Akita M, Takeda Y, Yamada S, Fujii H, Sawai Y, Doi Y, Asazawa H, Nakayama K, Mizutani K, Fujii H, Yakushijin T, Miyazaki M, Ezaki H, Hiramatsu N, Yoshida Y, Kiso S, Imai Y,Kawada N, Takehara T, Miyoshi E. PLoS One. 2013 Jun 21;8(6):e66328. Print 2013.
  Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis.
Kamada Y, Fujii H, Fujii H, Sawai Y, Doi Y, Uozumi N, Mizutani K, Akita M, Sato M, Kida S, Kinoshita N, Maruyama N, Yakushijin T, Miyazaki M, Ezaki H, Hiramatsu N, Yoshida Y, Kiso S, Imai Y,Kawada N, Takehara T, Miyoshi E. Proteomics Clin Appl. 2013 Jun 14. doi: 10.1002/prca.201200137.
  Cytoglobin may be involved in the healing process of gastric mucosal injuries in the late phase without angiogenesis.
Tanaka F, Tominaga K, Sasaki E, Sogawa M, Yamagami H, Tanigawa T, Shiba M,Watanabe K, Watanabe T, Fujiwara Y, Kawada N, Yoshizato K, Arakawa T. Dig Dis Sci. 2013 May;58(5):1198-206. doi:10.1007/s10620-012-2514-8.
  Serum amyloid A and C-reactive protein positive nodule in alcoholic liver cirrhosis, hard to make definite diagnosis.
Kim SR, Kondo F, Otono Y, Imoto S, Ando K, Hirakawa M, Fukuda K, Sasaki M, Kim SK, Komaki T, Tsuchida S, Kobayashi S, Matsuoka T, Kudo M. Hepatol Res. 2013 Apr 23. doi: 10.1111/hepr.12145.
  Treatment guidelines for HCV genotype 1: mono for low, triple for high, and dual for 'middle'?
Enomoto M, Tamori A, Kobayashi S, Iwai S, Morikawa H, Kawada N.
J Gastroenterol. 2013 Apr;48(4):555-6. doi: 10.1007/s00535-013-0759-4.
  A pregnant woman with acute hepatitis B in whom vertical transmission was prevented by tenofovir disoproxil fumarate
Tooyama M, Tamori A, Nakano A,Hao H, Thuy LTT, Enomoto M, Kawada N. Clin J Gastroenterol. 2013 Apr ; 6; 173-176.
A Phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin in cancer patients.
Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H. Cancer Chemotherapy and Pharmacology. 2013 Mar 30 doi: 10.1007/s00280-013-2151-8.
  Combination therapy of natural human interferon-beta and ribavirin for chronic hepatitis C patients with injection drug use.
Morikawa H, Kozuka R, Fujii H, Iwai S, Enomoto M, Tamori A, Saito S, Kawada N. Hepatol Res. 2013 Mar 27. doi: 10.1111/hepr.12066.
  The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis.
Murakami Y, Tamori A, Itami S, Tanahashi T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A, Kumada T, Kawada N, Kubo S, Kuroda M. BMC Cancer. 2013 Mar 4;13:99. doi: 10.1186/1471-2407-13-99.
  Entecavir and interferon-alpha sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B
著者名: Enomoto, M ; Nishiguchi, S ; Tamori, A ; Kobayashi, S ; Sakaguchi, H ; Shiomi, S ; Kim, SR ; Enomoto, H ; Saito, M ; Imanishi, H ; Kawada, N グループ著者名: B-Shot Study Grp
出版物名: JOURNAL OF GASTROENTEROLOGY 巻: 48 号: 3 ページ: 397-404 DOI: 10.1007/s00535-012-0645-5 発行: MAR 2013
  Assessment of liver fibrosis with real-time tissue elastography in chronic viral hepatitis.
Yada N, Kudo M, Morikawa H, Fujimoto K, Kato M, Kawada N. Oncology.2013;84 Suppl 1:13-20. doi: 10.1159/000345884. Epub 2013 Feb 20.
  Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C.
Yamaguchi T, Matsuzaki K, Inokuchi R, Kawamura R, Yoshida K, Murata M, Fujisawa J, Fukushima N, Sata M, Kage M, Nakashima O, Tamori A, Kawada N, Tsuneyama K, Dooley S, Seki T, Okazaki K. Hepatol Res. 2013 Feb 20. doi: 10.1111/hepr.12082.
  Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis.
Hayashi F, Matsumoto Y, Momoki C, Yuikawa M, Okada G, Hamakawa E, Kawamura E, Hagihara A, Toyama M, Fujii H, Kobayashi S, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N, Habu D. Hepatol Res. 2013 Feb 5. doi: 10.1111/hepr.12085.
  Higher Hepatic Gene Expression and Serum Levels of Matrix Metalloproteinase-2 are Associated with Steatohepatitis in Non-alcoholic Fatty Liver Diseases.
Toyoda H, Kumada T, Kiriyama T, Tanigawa M, Hisanaga Y, Kanamori A, Tada Y, and Murakami Y.
Biomarkers .February 2013, Vol. 18, No. 1 , Pages 82-87 (doi:10.3109/1354750X.2012.738249)
  Survey of non-B, non-C liver cirrhosis in Japan.
Suzuki Y, Ohtake T, Nishiguchi S, Hashimoto E, Aoyagi Y, Onji M, Kohgo Y; The Japan Non-B, Non-C Liver Cirrhosis Study Group. Hepatol Res. 2013 Jan 25. doi: 10.1111/hepr.12056.
  Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential.
simultaneous or sequential.
Enomoto M, Tamori A, Nishiguchi S, Kawada N.
J Gastroenterol. 2013 Jan 22.
Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
Kato J, Okamoto T, Motoyama H, Uchiyama R, Kirchhofer D, Van Rooijen N, Enomoto H, Nishiguchi S, Kawada N, Fujimoto J, Tsutsui H. Hepatology. 2013 Jan;57(1):362-72. doi: 10.1002/hep.26027.
  Principal Component Analysis Based Feature Extraction Approach to Identify Circulating microRNA Biomarkers.
著者名:Yoshihiro Taguchi, Yoshiki Murakami
出版物名: PLoS One. 2013 Jun 24;8(6):e66714. doi: 10.1371/journal.pone.0066714. Print 2013.
  Analysis of circulating microRNA by microarray in liver disease.
著者名:Yoshiki Murakami, Toshihito Tanahashi.
出版物名:Methods Mol Biol. 2013;1024:173-82. Humana Press 2013
YEAR TITLE & JOURNAL/AUTHORS
2012 Histopathological Diagnosis of Early HCC through Biopsy: Efficacy of Victoria Blue and Cytokeratin 7 Staining.
Kobayashi S, Kim SR, Imoto S, Ando K, Hirakawa M, Saito J, Fukuda K, Otono Y, Sakaki M, Tsuchida S, Kim SK, Hayashi Y, Nakano M, Kudo M.
Dig Dis. 2012;30(6):574-9. doi: 10.1159/000343069. Epub 2012 Dec 13.
  Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease.
Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, et al. (2012) Comprehensive miRNA Expression Analysis in Peripheral Blood Can Diagnose. Liver Disease.
PLoS ONE 7(10): e48366. doi:10.1371/journal.pone.0048366 Epub 2012 Oct 31.
Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis.
Hayashi F, Momoki C, Yuikawa M, Simotani Y, Kawamura E, Hagihara A, Fujii H, Kobayashi S, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N, Ohfuji S, Fukusima W, Habu D.
World J Gastroenterol. 2012 October 28; 18(40): 5759–5770.
High Prevalence of Gastroesophageal Reflux Symptoms in Patients with Non-Alcoholic Fatty Liver Disease Associated with Serum Levels of Triglyceride and Cholesterol but Not Simple Visceral Obesity.
Fujikawa Y, Tominaga K, Fujii H, Machida H, Okazaki H, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Fujiwara Y, Matsuura T, Kawada N, Arakawa T.
Digestion. 2012 Sep 5;86(3):228-237.
  Anti-hepatitis B virus therapy: To stop, or not to stop: Has the question been solved?
Kozuka R, Enomoto M, Morikawa H, Tamori A, Kawada N.
Hepatol Res. 2012 Sep;42(9):946-7.
  Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B.
Enomoto M, Nishiguchi S, Tamori A, Kobayashi S, Sakaguchi H, Shiomi S, Kim SR, Enomoto H, Saito M, Imanishi H, Kawada N.
J Gastroenterol. 2012 Aug 2. [Epub ahead of print]
  Inhibition of the activation of hepatic stellate cells by arundic acid via the induction of cytoglobin.
Cui W, Wang M, Maegawa H, Teranishi Y, Kawada N.
Biochem Biophys Res Commun. 2012 Aug 31;425(3):642-8.
  Induction of microRNA-214-5p in human and rodent liver fibrosis.
Iizuka M, Ogawa T, Enomoto M, Motoyama H, Yoshizato K, Ikeda K, Kawada N.
Fibrogenesis Tissue Repair. 2012 Aug 1;5(1):12.
  Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C.
Ohfuji S, Fukushima W, Tamori A, Maeda K, Maeda A, Hirota Y.
Influenza Other Respi Viruses. 2012 Aug 16.
Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.
Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, Hige S, Kang JH, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M.
PLoS One. 2012;7(6):e39175. Epub 2012 Jun 21.
  Changes in sequences of core region, interferon sensitivity-determining region and interferon and ribavirin resistance-determining region of hepatitis C virus genotype 1 during interferon-alpha and ribavirin therapy, and efficacy of retreatment.
Kozuka R, Enomoto M, Hai H, Ogawa T, Nakaya M, Hagihara A, Fujii H, Kobayashi S, Iwai S, Morikawa H, Tamori A, Kawada N.
Hepatol Res. 2012 May 3. doi: 10.1111/j.1872-034X.2012.01046.x.
[Epub ahead of print]
  Antifibrotic role of macrophage migration inhibitory factor: discovery of an unexpected function.
Thuy le TT, Kawada N. Hepatology. 2012 Apr;55(4):1295-7.
  Effect of mosapride citrate on gastric emptying in interferon-induced gastroparesis.
Kawamura E, Enomoto M, Kotani K, Hagihara A, Fujii H, Kobayashi S, Iwai S, Morikawa H, Kawabe J, Tominaga K, Tamori A, Shiomi S, Kawada N.
Dig Dis Sci. 2012 Jun;57(6):1510-6.
  Benefits of Artificially Induced Pleural Effusion and/or Ascites for Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma Located on the Liver Surface and in the Hepatic Dome.
Iwai S, Sakaguchi H, Fujii H, Kobayashi S, Morikawa H, Enomoto M, Tamori A, Kawada N. Hepatogastroenterology. 2012 Mar-Apr;59(114):546-50.
Response-guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2.
Yamaguchi Y, Tamori A, Tanaka Y, Iwai S, Kobayashi S, Fujii H, Morikawa H, Hagihara A, Enomoto M, Kawada N. Hepatol Res. 2012 Jun;42(6):549-57.
  Inflammation and fibrogenesis in steatohepatitis.
Fujii H, Kawada N. J Gastroenterol. 2012 Mar;47(3):215-25.
  N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis.
Kamada Y, Mori K, Matsumoto H, Kiso S, Yoshida Y, Shinzaki S, Hiramatsu N, Ishii M, Moriwaki K, Kawada N, Takehara T, Miyoshi E. Glycobiology. 2012 Jun;22(6):778-87.
  MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N.
Gut. 2012 Jan 20. [Epub ahead of print]
  Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.
Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). BMC Gastroenterol. 2012 Jan 5;12:2.
  Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway.
Uyama N, Iimuro Y, Kawada N, Reynaert H, Suzumura K, Hirano T, Kuroda N, Fujimoto J. Lab Invest. 2012 Jan;92(1):57-71.
  Age and total ribavirin dose are independent predictors of relapse after interferon therapy in chronic hepatitis C revealed by data mining analysis.
Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, Iwasaki M, Tamori A, Matsuura K, Kakinuma S, Sugauchi F, Sakamoto N, Nakagawa M, Yatsuhashi H, Izumi N.
Antivir Ther. 2012;17(1):35-43.
  Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections.
Tani Y, Aso H, Matsukura H, Tadokoro K, Tamori A, Nishiguchi S, Yoshizawa H, Shibata H; JRC NAT Screening Research Group.
Vox Sang.2012 May;102(4):285-93.
Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.
Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, Iwasaki M, Tamori A, Matsuura K, Kakinuma S, Sugauchi F, Sakamoto N, Nakagawa M, Izumi N.
J Hepatol. 2012 Mar;56(3):602-8.
  Gemcitabine-induced Pleuropericardial Effusion in a Patient with Pancreatic Cancer.
Kido H, Morizane C, Tamura T, Hagihara A, Kondo S, Ueno H, Okusaka T.
Jpn J Clin Oncol. 2012 Jul 10. [Epub ahead of print]
  Successful control of intractable hypoglycemia using radiopharmaceutical therapy with strontium-89 in a case with malignant insulinoma and bone metastases. Naganuma A, Mayahara H, Morizane C, Ito Y, Hagihara A, Kondo S, Ueno H, Itami J, Okusaka T.
Jpn J Clin Oncol. 2012 Jul;42(7):640-5. Epub 2012 Apr 23.
  Role of miR-19b and its target mRNAs on 5-fluorouracil resistance in colon cancer cells
Kurokawa K, Tanahashi T, Iima T, Yamamoto Y, Akaike, Y, Nishida K, Masuda K, Kuwano Y, Murakami Y, Fukushima M, Rokutan K.. J Gastoroenterol. 2012 Mar 1
  Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b.
Toyoda H, Kumada T, Tada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F.
J Med Virol. 2012 Jan;84(1):61-70. doi: 10.1002/jmv.22272.
  Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically-resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene.
Toyoda H, Kumada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F. J Med Virol 2012; 84: 61-70
YEAR TITLE & JOURNAL/AUTHORS
2011 Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections.
Tani Y, Aso H, Matsukura H, Tadokoro K, Tamori A, Nishiguchi S, Yoshizawa H, Shibata H; JRC NAT Screening Research Group.
Vox Sang. 2011 Nov 14
  Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway.
Uyama N, Iimuro Y, Kawada N, Reynaert H, Suzumura K, Hirano T, Kuroda N, Fujimoto J.
Lab Invest. 2011 Oct 17. doi: 10.1038/labinvest.2011.150. [Epub ahead of print]
  Could trastuzumab suppress hepatitis C virus in a patient with chronic hepatitis and breast cancer?
Tamori A, Kawajiri H, Takashima T, Motoyama H, Morikawa H, Enomoto M, Hirakawa K, Kawada N.
Am J Gastroenterol. 2011 Oct;106(10):1865-6. doi: 10.1038/ajg.2011.258. No abstract available.
  Favorable factors for re-treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus.
Tamori A, Kioka K, Kurai O, Sakaguchi H, Enomoto M, Fujii H, Kobayashi S, Iwai S, Morikawa H, Yamaguchi S, Kawasaki Y, Oka H, Tanaka Y, Kawada N.
Hepatol Res. 2011 Dec;41(12):1169-77. doi: 10.1111/j.1872-034X.2011.00887.x. Epub 2011 Sep 26.
Suppression of hepatic stellate cell activation by microRNA-29b.
Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N.
Biochem Biophys Res Commun. 2011 Aug 19;412(1):74-9. Epub 2011 Jul 21.
  Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation.
Sekiya Y, Ogawa T, Iizuka M, Yoshizato K, Ikeda K, Kawada N.
J Cell Physiol. 2011 Oct;226(10):2535-42. doi: 10.1002/jcp.22598.
  Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.
Yoneda M, Fujii H, Sumida Y, Hyogo H, Itoh Y, Ono M, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Imajo K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).
J Gastroenterol. 2011 Nov;46(11):1300-6. Epub 2011 Jul 13.
  High prevalence of hepatitis C virus infection in Airin district, Osaka, Japan: A hospital-based study of 1162 patients.
Yamaguchi Y, Enomoto M, Fujii H, Tamori A, Sakaguchi H, Tanigawa T, Watanabe K, Fujiwara Y, Arakawa T, Harihara S, Monna T, Kawada N.
Hepatol Res. 2011 Aug;41(8):731-7. doi: 10.1111/j.1872-034X.2011.00834.x. Epub 2011 Jun 28.
  Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice.
Thuy le TT, Morita T, Yoshida K, Wakasa K, Iizuka M, Ogawa T, Mori M, Sekiya Y, Momen S, Motoyama H, Ikeda K, Yoshizato K, Kawada N.
Am J Pathol. 2011 Aug;179(2):1050-60. Epub 2011 Jun 2.
Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non-alcoholic fatty liver disease.
Mori M, Fujii H, Ogawa T, Kobayashi S, Iwai S, Morikawa H, Enomoto M, Tamori A, Sawada A, Takeda S, Kawada N.
Hepatol Res. 2011 Sep;41(9):897-903. doi: 10.1111/j.1872-034X.2011.00842.x. Epub 2011 Jun 17.
  Cytoglobin expression of rectal subepithelial myofibroblasts: significant alterations of cytoglobin+ stromal cells in long-standing ulcerative colitis.
Okayasu I, Mikami T, Yoshida T, Hana K, Yokozawa M, Sada M, Fujiwara M, Kawada N.
Histol Histopathol. 2011 Jun;26(6):679-88.
  Evolution of hepatic fibrosis research.
Kawada N.
Hepatol Res. 2011 Mar;41(3):199-208. doi: 10.1111/j.1872-034X.2011.00776.x.
  Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.
Tamori A, Koike T, Goto H, Wakitani S, Tada M, Morikawa H, Enomoto M, Inaba M, Nakatani T, Hino M, Kawada N.
J Gastroenterol. 2011 Apr;46(4):556-64. Epub 2011 Jan 19.
Cytoglobin, a novel member of the globin family, protects kidney fibroblasts against oxidative stress under ischemic conditions.
Nishi H, Inagi R, Kawada N, Yoshizato K, Mimura I, Fujita T, Nangaku M.
Am J Pathol. 2011 Jan;178(1):128-39. Epub 2010 Dec 23.
  A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.
Sumida Y, Yoneda M, Hyogo H, Yamaguchi K, Ono M, Fujii H, Eguchi Y, Suzuki Y, Imai S, Kanemasa K, Fujita K, Chayama K, Yasui K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).
J Gastroenterol. 2011 Feb;46(2):257-68. Epub 2010 Sep 15.
  Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C.
Morikawa H, Fukuda K, Kobayashi S, Fujii H, Iwai S, Enomoto M, Tamori A, Sakaguchi H, Kawada N.
J Gastroenterol. 2011 Mar;46(3):350-8. Epub 2010 Aug 10.
  Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.
Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, Iwasaki M, Tamori A, Matsuura K, Kakinuma S, Sugauchi F, Sakamoto N, Nakagawa M, Izumi N.
J Hepatol. 2011 Oct 22. [Epub ahead of print]
Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis.
Hiramatsu N, Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Sugauchi F, Tamori A, Kakinnuma S, Matsuura K, Izumi N.
J Gastroenterol. 2011 Sep;46(9):1111-9. Epub 2011 Jun 17.
  Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b. 
Sakamoto N, Nakagawa M, Tanaka Y, Sekine-Osajima Y, Ueyama M, Kurosaki M, Nishida N, Tamori A, Yuki NS, Itsui Y, Azuma S, Kakinuma S, Hige S, Itoh Y, Tanaka E, Hiasa Y, Izumi N, Tokunaga K, Mizokami M, Watanabe M; Ochanomizu-Liver Conference Study Group.
J Med Virol. 2011 May;83(5):871-8. doi: 10.1002/jmv.22038. Epub 2011 Feb 25.
  Investigation of interferon-α response by a single amino acid substitution of nonstructural protein 5A in hepatitis C virus-infected patients.
Noguchi T, Tamori A, Ogura N, Hori Y, Ikeda S, Nishiguchi S.
J Interferon Cytokine Res. 2011 Aug;31(8):589-99. doi: 10.1089/jir.2010.0128. Epub 2011 Feb 25.
  Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: data mining analysis.
Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Hiramatsu N, Sugauchi F, Tamori A, Nakagawa M, Izumi N.
J Med Virol. 2011 Mar;83(3):445-52. doi: 10.1002/jmv.22005.
Non-invasive diagnosis of liver fibrosis
Morikawa H, Kawada N
Clin J Gastroenterol (2011) 4:283–291 DOI 10.1007/s12328-011-0248-3
  Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. 
Iwasa S, Ikeda M, Okusaka T, Ueno H, Morizane C, Nakachi K, Mitsunaga S, Kondo S, Hagihara A, Shimizu S, Satake M, Arai Y.
Jpn J Clin Oncol. 2011 Jun;41(6):770-5. Epub 2011 Apr 1
YEAR TITLE & JOURNAL/AUTHORS
2010 Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation.
Sekiya Y, Ogawa T, Iizuka M, Yoshizato K, Ikeda K, Kawada N.
J Cell Physiol. 2010 Dec 29. [Epub ahead of print]
Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy.
Enomoto M, Mori M, Ogawa T, Fujii H, Kobayashi S, Iwai S, Morikawa H, Tamori A, Sakaguchi H, Sawada A, Takeda S, Habu D, Shiomi S, Kawada N.
Hepatol Res. 2010 Sep;40(9):853-61.
A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.
Sumida Y, Yoneda M, Hyogo H, Yamaguchi K, Ono M, Fujii H, Eguchi Y, Suzuki Y, Imai S, Kanemasa K, Fujita K, Chayama K, Yasui K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).
J Gastroenterol. 2010 Sep 15. [Epub ahead of print]
  Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C.
Morikawa H, Fukuda K, Kobayashi S, Fujii H, Iwai S, Enomoto M, Tamori A, Sakaguchi H, Kawada N.
J Gastroenterol. 2010 Aug 10. [Epub ahead of print]
A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits.
Ogawa T, Fujii H, Yoshizato K, Kawada N.
Am J Pathol. 2010 Jul;177(1):153-65. Epub 2010 May 20.
  Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009).
Namiki I, Nishiguchi S, Hino K, Suzuki F, Kumada H, Itoh Y, Asahina Y, Tamori A, Hiramatsu N, Hayashi N, Kudo M.
Hepatol Res. 2010 Apr;40(4):347-68.
  Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development.
Spector I, Honig H, Kawada N, Nagler A, Genin O, Pines M.
Pancreas. 2010 Apr 30. [Epub ahead of print]
  Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet.
Mu YP, Ogawa T, Kawada N.
Lab Invest. 2010 Feb;90(2):245-56. Epub 2009 Nov 30.
  Suppression of type I collagen production by microRNA-29b in cultured human stellate cells.
Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N.
Biochem Biophys Res Commun. 2010 Jan 1;391(1):316-21. Epub 2009 Nov 12.
  Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus.
Tamori A, Enomoto M, Kobayashi S, Iwai S, Morikawa H, Sakaguchi H, Habu D, Shiomi S, Imanishi Y, Kawada N.
J Viral Hepat. 2010 Feb 1;17(2):123-9. Epub 2009 Aug 5.
YEAR TITLE & JOURNAL/AUTHORS
2009 Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning.
Fujii H, Ikura Y, Arimoto J, Sugioka K, Iezzoni JC, Park SH, Naruko T, Itabe H, Kawada N, Caldwell SH, Ueda M.
J Atheroscler Thromb. 2009;16(6):893-901. Epub 2009 Dec 22.
  Emerging antiviral drugs for hepatitis C virus.
Enomoto M, Tamori A, Kawada N.
Rev Recent Clin Trials. 2009 Sep;4(3):179-84.
  Applicability of BARD score to Japanese patients with NAFLD.
Fujii H, Enomoto M, Fukushima W, Tamori A, Sakaguchi H, Kawada N.
Gut. 2009 Nov;58(11):1566-7; author reply 1567.
  Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization.
Kobayashi S, Sakaguchi H, Takatsuka M, Suekane T, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N.
Hepatol Int. 2009 Jun;3(2):416-20. Epub 2009 Mar 5.
  Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis.
Otogawa K, Ogawa T, Shiga R, Ikeda K, Kawada N.
Hepatol Int. 2009 Jun;3(2):378-83. Epub 2008 Dec 10.
  Effect of natural interferon alpha on proliferation and apoptosis of hepatic stellate cells.
Ogawa T, Kawada N, Ikeda K. Hepatol Int. 2009 Apr 21.
  A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status.
Kawamura E, Habu D, Morikawa H, Enomoto M, Kawabe J, Tamori A, Sakaguchi H, Saeki S, Kawada N, Shiomi S.
Liver Transpl. 2009 Jul;15(7):790-7.
  Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
Tamori A, Hayashi T, Shinzaki M, Kobayashi S, Iwai S, Enomoto M, Morikawa H, Sakaguchi H, Shiomi S, Takemura S, Kubo S, Kawada N.
J Med Virol. 2009 Jun;81(6):1009-14.
  Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis. Fujii H, Enomoto M, Fukushima W, Ohfuji S, Mori M, Kobayashi S, Iwai S, Morikawa H, Tamori A, Sakaguchi H, Ikura Y, Ueda M, Kawada N.
J Gastroenterol. 2009;44(6):608-14. Epub 2009 Apr 10.
  Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium.
Smedsrød B, Le Couteur D, Ikejima K, Jaeschke H, Kawada N, Naito M, Knolle P, Nagy L, Senoo H, Vidal-Vanaclocha F, Yamaguchi N.
Liver Int. 2009 Apr;29(4):490-501. Epub 2009 Jan 31. Review.
  Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
Zion O, Genin O, Kawada N, Yoshizato K, Roffe S, Nagler A, Iovanna JL, Halevy O, Pines M. Pancreas. 2009 May;38(4):427-35.
Endoscopic thermal ablation therapies for hepatocellular carcinoma: a multi-center study.
Sakaguchi H, Seki S, Tsuji K, Teramoto K, Suzuki M, Kioka K, Isoda N, Ido K
Hepatol Res. 2009 Jan 1;39(1):47-52.
Sildenafil-induced severe cholestatic hepatotoxicity.
Enomoto M, Sakaguchi H, Ominami M, Iwai S, Morikawa H, Tamori A, Kawada N.
Am J Gastroenterol. 2009 Jan;104(1):254-5.No abstract available.
YEAR TITLE & JOURNAL/AUTHORS
2008 A case of primary small cell carcinoma of the liver that was treated with chemotherapy.
Morikawa H, Nakayama Y, Maeda T, Nadatani Y, Kobayashi S, Iwai S, Enomoto M, Tamori A, Sakaguchi H, Oshitani N, Kudoh S, Kawada N.
Hepatol Int. 2008 Dec;2(4):500-4. Epub 2008 Aug 22.
  Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis.
Enomoto M, Nakanishi T, Ishii M, Tamori A, Kawada N.
Ann Intern Med. 2008 Dec 16;149(12):912-3. No abstract available. Erratum in: Ann Intern Med. 2009 Mar 17;150(6):432. Nakamishi, Takeshi [corrected to Nakanishi, Takeshi].
  [Drug-induced liver injury caused by an herbal medicine, bofu-tsu-sho-san] Motoyama H, Enomoto M, Yasuda T, Fujii H, Kobayashi S, Iwai S, Morikawa H, Takeda T, Tamori A, Sakaguchi H, Kawada N.
Nippon Shokakibyo Gakkai Zasshi. 2008 Aug;105(8):1234-9. Review. Japanese.
  Platelet-associated IgG for the diagnosis of immune thrombocytopaenic purpura during peginterferon alpha and ribavirin treatment for chronic hepatitis C.
Enomoto M, Yamane T, Hino M, Ohnishi M, Tamori A, Kawada N.
Liver Int. 2008 Nov;28(9):1314-5. Epub 2008 Jul 24. No abstract available.
  Clinical role of FDG-PET for HCC: relationship of glucose metabolic indicator to Japan Integrated Staging (JIS) score.
Kawamura E, Habu D, Ohfuji S, Fukushima W, Enomoto M, Torii K, Kawabe J, Kondo K, Tamori A, Kawada N, Shiomi S.
Hepatogastroenterology. 2008 Mar-Apr;55(82-83):582-6.
  Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C?
Ohfuji S, Fukushima W, Tanaka T, Habu D, Takeda T, Tamori A, Sakaguchi H, Seki S, Kawada N, Nishiguchi S, Shiomi S, Hirota Y.
Hepatol Res. 2008 Sep;38(9):860-8. Epub 2008 May 27.
  Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial.
Enomoto M, Tamori A, Kohmoto MT, Hayashi T, Morikawa H, Jomura H, Sakaguchi H, Habu D, Kawada N, Shiomi S, Nishiguchi S.
Hepatol Res. 2008 Sep;38(9):954-9. Epub 2008 May 20.
  Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection. Hayashi T, Tamori A, Nishikawa M, Morikawa H, Enomoto M, Sakaguchi H, Habu D, Kawada N, Kubo S, Nishiguchi S, Shiomi S.
Liver Int. 2009 Jan;29(1):126-32. Epub 2008 May 19.
  Attenuation of acute and chronic liver injury in rats by iron-deficient diet. Otogawa K, Ogawa T, Shiga R, Nakatani K, Ikeda K, Nakajima Y, Kawada N.
Am J Physiol Regul Integr Comp Physiol. 2008 Feb;294(2):R311-20. Epub 2007 Nov 21.
YEAR TITLE & JOURNAL/AUTHORS
2007 Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.
J Med Virol. 2007 Nov;79(11):1664-70.
  Characterization of vitamin A-storing cells in mouse fibrous kidneys using Cygb/STAP as a marker of activated stellate cells.
Kida Y, Asahina K, Inoue K, Kawada N, Yoshizato K, Wake K, Sato T.
Arch Histol Cytol. 2007 Jul;70(2):95-106.
  Role of oxidative stress and Kupffer cells in hepatic fibrosis.
Kawada N, Otogawa K.
J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S85-6.
  Expression of connective tissue growth factor in the human liver with idiopathic portal hypertension.
Morikawa H, Tamori A, Nishiguchi S, Enomoto M, Habu D, Kawada N, Shiomi S.
Mol Med. 2007 May-Jun;13(5-6):240-5.
  A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET.
Kawamura E, Habu D, Higashiyama S, Tsushima H, Shimonishi Y, Nakayama Y, Enomoto M, Kawabe J, Tamori A, Kawada N, Shiomi S.
Ann Nucl Med. 2007 Jun;21(4):223-8. Epub 2007 Jun 25.
  Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection.
Enomoto M, Tamori A, Kohmoto MT, Hayashi T, Jomura H, Habu D, Sakaguchi H, Takeda T, Kawada N, Seki S, Shiomi S, Koh N, Nishiguchi S.
Cytokine Res. 2007 Mar;27(3):201-7.
  Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. Otogawa K, Kinoshita K, Fujii H, Sakabe M, Shiga R, Nakatani K, Ikeda K, Nakajima Y, Ikura Y, Ueda M, Arakawa T, Hato F, Kawada N.
Am J Pathol. 2007 Mar;170(3):967-80.
  Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
Kobayashi S, Takeda T, Enomoto M, Tamori A, Kawada N, Habu D, Sakaguchi H, Kuroda T, Kioka K, Kim SR, Kanno T, Ueda T, Hirano M, Fujimoto S, Jomura H, Nishiguchi S, Seki S.
Liver Int. 2007 Mar;27(2):186-91.
  Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect.
Sheffer Y, Leon O, Pinthus JH, Nagler A, Mor Y, Genin O, Iluz M, Kawada N, Yoshizato K, Pines M.
Cancer Ther. 2007 Feb;6(2):570-7. Epub 2007 Jan 31.
  Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.
Tamori A, Shinzaki M, Kosaka S, Hayashi T, Iwai S, Enomoto M, Habu D, Sakaguchi H, Kawada N, Hino M, Shiomi S, Nishiguchi S.
Liver Int. 2007 Feb;27(1):95-100.
  Rho kinase inhibitor Y27632 affects initial heart myofibrillogenesis in cultured chick blastoderm.
Sakata H, Sakabe M, Matsui H, Kawada N, Nakatani K, Ikeda K, Yamagishi T, Nakajima Y. Dev Dyn. 2007 Feb;236(2):461-72.
  Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C.
El-Karef A, Kaito M, Tanaka H, Ikeda K, Nishioka T, Fujita N, Inada H, Adachi Y, Kawada N, Nakajima Y, Imanaka-Yoshida K, Yoshida T.
J Hepatol. 2007 Apr;46(4):664-73. Epub 2006 Nov 27.
  Laparoscopic observation of 2 cases of nodular regenerative hyperplasia of the liver.
Fujii H, Sakaguchi H, Enomoto M, Yamamori K, Inagawa M, Watanabe T, Kawada N, Seki S, Arakawa T.
Gastrointest Endosc. 2007 Jan;65(1):171-3.No abstract available.
  Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.
Gnainsky Y, Kushnirsky Z, Bilu G, Hagai Y, Genina O, Volpin H, Bruck R, Spira G, Nagler A, Kawada N, Yoshizato K, Reinhardt DP, Libermann TA, Pines M.
Cell Tissue Res. 2007 Apr;328(1):153-66. Epub 2006 Dec 19.
  Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats.
Kinoshita K, Iimuro Y, Otogawa K, Saika S, Inagaki Y, Nakajima Y, Kawada N, Fujimoto J, Friedman SL, Ikeda K.
Gut. 2007 May;56(5):706-14. Epub 2006 Nov 24.
  Identification of vitamin A-free cells in a stellate cell-enriched fraction of normal rat liver as myofibroblasts.
Ogawa T, Tateno C, Asahina K, Fujii H, Kawada N, Obara M, Yoshizato K.
Histochem Cell Biol. 2007 Feb;127(2):161-74. Epub 2006 Oct 6.
  Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis.
Kinoshita K, Iimuro Y, Fujimoto J, Inagaki Y, Namikawa K, Kiyama H, Nakajima Y, Otogawa K, Kawada N, Friedman SL, Ikeda K.
Gut. 2007 Mar;56(3):396-404. Epub 2006 Sep 6.
YEAR TITLE & JOURNAL/AUTHORS
2006 Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study.
Ohfuji S, Fukushima W, Tanaka T, Habu D, Tamori A, Sakaguchi H, Takeda T, Kawada N, Seki S, Nishiguchi S, Shiomi S, Hirota Y.
Hepatol Res. 2006 Nov;36(3):201-8. Epub 2006 Aug 17.
  Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease.
Kawada N.  Gut. 2006 Aug;55(8):1073-4. Review.No abstract available.
  [Rabbit model for the study of human NASH]
Otogawa K, Kawada N.
Nippon Rinsho. 2006 Jun;64(6):1043-7. Review. Japanese
  High-resolution structure of human cytoglobin: identification of extra N- and C-termini and a new dimerization mode.
Makino M, Sugimoto H, Sawai H, Kawada N, Yoshizato K, Shiro Y.
Acta Crystallogr D Biol Crystallogr. 2006 Jun;62(Pt 6):671-7. Epub 2006 May 12.
  Cancer serum proteomics in gastroenterology.
Kawada N.  Gastroenterology. 2006 May;130(6):1917-9.No abstract available.
  Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression.
Ikura Y, Ohsawa M, Suekane T, Fukushima H, Itabe H, Jomura H, Nishiguchi S, Inoue T, Naruko T, Ehara S, Kawada N, Arakawa T, Ueda M.
Hepatology. 2006 Mar;43(3):506-14.
  Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection?
Fukushima W, Tanaka T, Ohfuji S, Habu D, Tamori A, Kawada N, Sakaguchi H, Takeda T, Nishiguchi S, Seki S, Shiomi S, Hirota Y.
Hepatol Res. 2006 Mar;34(3):141-9. Epub 2006 Jan 19.
  Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial.
Enomoto M, Tamori A, Kawada N, Jomura H, Nishiguchi S, Saibara T, Onishi S, Mochida S, Fujiwara K.
Gut. 2006 Jan;55(1):139-40.No abstract available.
  Rho kinases regulate endothelial invasion and migration during valvuloseptal endocardial cushion tissue formation.
Sakabe M, Ikeda K, Nakatani K, Kawada N,Imanaka-Yoshida K, Yoshida T, Yamagishi T, Nakajima Y.
Dev Dyn. 2006 Jan;235(1):94-104.
  BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2.
Izumi N, Mizuguchi S, Inagaki Y, Saika S, Kawada N, Nakajima Y, Inoue K, Suehiro S, Friedman SL, Ikeda K.
Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L120-6. Epub 2005 Aug 26.
和文
タイトル・著者
2016
当院における肝炎ウイルス検査の実施状況と陽性者に対する受診勧奨システム構築による院内連携の変化について
author: 打田(小林)佐和子、榎本大、藤井英樹、飯田(上野)綾子、元山宏行、小塚立蔵、萩原淳司、川村悦史、森川浩安、村上善基、田守昭博、河田則文
source: 肝臓 47巻1号 7-16 (2016)
 
症例報告:ダクラタスビル/アスナプレビル治療が著効したクリオグロブリン血管炎合併C型慢性肝疾患の一例
author: 高田さゆり、打田(小林)佐和子、飯田(上野)綾子、寺西優雅、元山宏行、小塚立蔵、川村悦史、萩原淳司、石津弘隆、森川浩安、榎本大、村上善基、田守昭博、河田則文
source: 肝臓 57; 328-333, 2016
 
アルコール使用障害特定テスト(AUDIT)スコアは飲酒量の推定に有用である
author: 藤井 英樹、西本 尚樹、宮野 正人、上田 渉、大庭 宏子、山口 誓子、青木 哲哉、倉井 修、河田 則文、大川清孝
source: 日本アルコール・薬物医学会雑誌2016
 
C型肝炎治療薬Q&A:服薬アドヒアランスの維持に有用な対策とは?
author: 榎本 大
source: P74−75,2016.3創刊
 
成因別の病態と治療:B型肝硬変、肝硬変マネジメント(改訂3版)
author: 榎本 大
source: 医薬ジャーナル社 P.131−139 2016.11発刊
 
【門脈圧亢進症の制御-病態研究と治療の進展】概念、機序、診断 視点を変えた門脈圧亢進病態について
消化管との関連、IPHについて(解説/特集)

author: 森川 浩安、河田 則文
source: 肝・胆・膵(-389-4991)72巻2号 PAGE 191-195(2016.2)
 
合成二糖類の投与は肝不全患者の予後を改善する
author: 川村 悦史、河田 則文
source: 救急・集中治療第28巻 P.464-469.5月
 
初発時から根治不能の進行がんのマネジメント「肝癌」
author: 萩原淳司
source: Hospitalist(ホスピタリスト) Vol.4 No.3 P501-505, 2016
 
直接作用方型抗ウイルス薬(DAAs)によるC型慢性肝疾患診療
author: 田守昭博
source: 四国医誌 72;9-12, 2016
 
免疫抑制時のB型肝炎対策
author: 田守昭博
source: 腎と透析 診療指針 2016 80巻;171-173,2016
 
肝線維化進展の分子機構
author: 松原三佐子、河田 則文
source: 肝胆膵 73(6):873−879, 2016
タイトル・著者
2015
【肝疾患診療の新展開】肝星細胞と肝線維化(解説/特集)
Author:河田 則文(大阪市立大学 大学院医学研究科肝胆膵病態内科学)
Source: 日本医師会雑誌 (0021-4493)144巻7号 Page1428(2015.10)
  【消化器疾患の治療・検査で使われる薬・休薬する薬】 C型慢性肝炎治療に使う薬と今後の動向(解説/特集)
Author:小塚 立蔵(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田 則文
Source: 消化器最新看護 20巻3号 Page61-67(2015.08)
  【肝がん治療戦略のUp to Date】 抗ウイルス治療による肝発癌ならびに肝癌再発予防の可能性(解説/特集)
Author:打田 佐和子(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田 則文
Source: 癌の臨床 (0021-4949)61巻3号 Page229-235(2015.07)
  【いまB型・C型肝炎をどう治療するか】 【B型肝炎】B型肝炎ウイルス再活性化にどう対応するか(解説/特集)
Author:田守 昭博(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田 則文
Source: 消化器の臨床 (1344-3070)18巻1号 Page44-47(2015.02)
  血中miRNAによる肝疾患診断
author: 伊丹沙織 村上善基
source: 医学のあゆみ 2015; 255:231-235
タイトル・著者
2014
【GERDと生活習慣病】 NAFLDでは血清脂質によってGERD症状が誘発される(原著論文/特集)
藤川 佳子, 富永 和作, 藤井 英樹, 谷川 徹也, 渡辺 俊雄, 藤原 靖弘, 河田 則文, 荒川 哲男
消化器内科 (1884-2895)59巻4号 Page314-319(2014.10)
  ウイルス感染と分泌型microRNA
松本佳也、伊丹沙織、村上善基
肝疾患review 2014(2014.06)
  【肝硬変-診断と治療の進歩】 肝線維化機序研究の進歩(解説/特集)
Author:河田 則文(大阪市立大学 大学院医学研究科肝胆膵病態内科学) Source:臨床消化器内科(0911-601X)29巻4号 Page421-427(2014.03)
  細胞増殖 miRNA-195によるサイクリンE1の発現抑制(解説)
Author:河田 則文(大阪市立大学 大学院医学研究科肝胆膵病態内科学) Source:生体の科学(0370-9531)65巻1号 Page74-79(2014.02)
タイトル・著者
2013 Daclatasvir併用interferon療法
Author:田守昭博、河田則文
Source:肝胆膵 2013,12, 67: 913-917.
  肝臓とサイトグロビン
Author:元山宏行、Le Thi Thanh Thuy、河田 則文
Source:細胞(597-646)45巻13号 Page609-612(2013.12)
  長期観察によるHBV再活性化の頻度と治療介入例の予後
Author:田守昭博、榎本 大、多田昌弘、小池達也、河田則文
Source:消化器内科 2013,11, 57: 586-590.

【解剖がわかれば走査がわかる 決定版 超音波検査テクニックマスター 腹部・下肢編】 (第3章)症例編 Budd-Chiari症候群(解説/特集)
Author:打田 佐和子, 元山 宏行, 河田 則文
Source:Vascular Lab(1349-4023)10巻増刊 Page201-205(2013.10)
  What's New in SURGERY FRONTIER(第78回) 臓器星細胞の機能 肝線維化と星細胞
Author:河田 則文
Source:Surgery Frontier(1340-5594)20巻3号 Page312-315(2013.09)
【特集/疾患ゲノム研究のLandscape】エクソソーム中マイクロRNAを利用した慢性肝疾患診断法の開発
村上善基、河田則文、棚橋俊仁、田口善弘
Source: 肝胆膵67巻1号(2013年7月号)
  サイトグロビン研究の現況と展望
Author:河田 則文
Source:日本臨床(0047-1852)71巻5号 Page927-935(2013.05)
【B型肝炎再活性化の現状と対策-肝臓、血液、リウマチ、腫瘍領域の現状を踏まえて-】 大阪市立大学におけるB型肝炎再活性化前向き研究について
田守 昭博, 河田 則文
Source:最新医学(0370-8241)68巻3号 Page389-394(2013.03)
  経カテーテル的肝動脈塞栓術後に腫瘍崩壊症候群をきたした肝細胞癌の1例(原著論文/症例報告)
Author:西田 裕, 藤井 英樹, 萩原 淳司, 川村 悦史, 岩井 秀司, 榎本 大, 田守 昭博, 荒川 哲男, 河田 則文
Source:日本消化器病学会雑誌(0446-6586)110巻3号 Page441-448(2013.03).
  【肝線維化研究Update-基礎から臨床へ】 肝線維化病態へのマイクロRNAの関与
Author:池田 一雄, 河田 則文
Source:医学のあゆみ(0039-2359)244巻6号 Page521-525(2013.02)
  【肝線維化研究Update-基礎から臨床へ】 Elastographyによる肝の弾性度診断 肝硬度測定
森川 浩安, 河田 則文
Source:医学のあゆみ(0039-2359)244巻6号 Page544-548(2013.02)
【特集/疾患エクソソーム】肝疾患における miRNA 診断
村上善基、棚橋俊仁、田口善弘 
Source:細胞工学 2013; 1:79-84
タイトル・著者
2012 急性肝不全を呈するマクロファージ活性化症候群を合併した成人発症Still病の1例(原著論文)
・Author:藤井英樹(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 武田翔伍, 浅井哲, 林良樹, 今西久幹, 榎本大, 石井正光, 日野雅之, 根来伸夫, 荒川哲男, 河田則文
・Source:肝臓(0451-4203)53巻3号 Page155-163(2012.03)
  【抗ウイルス薬-最新の動向-】 抗ウイルス薬の特性と適応・使い分け 抗肝炎ウイルス薬、インターフェロン製剤 インターフェロン製剤(解説/特集)
Author:田守昭博(大阪市立大学 大学院医学研究科肝胆膵病態内科学),
河田則文
・Source:日本臨床(0047-1852)70巻4号 Page620-624(2012.04)
  【肝硬変Update-肝硬変死の根絶をめざして】 病態の理解 肝線維化の機序とその制御(解説/特集) 
・Author:元山宏行(大阪市立大学 大学院医学研究科肝胆膵病態内科学),
河田則文
・Source:医学のあゆみ(0039-2359)240巻9号 Page699-704(2012.03)
  インターフェロンβ治療が無効であったC型肝炎合併血液透析患者に対し、ペグインターフェロンα-2aによる再治療でSVRが得られた1症例(原著論文/症例報告)
・Author:山川健次郎(仁真会白鷺病院), 小林佐和子, 庄司繁市, 山川智之
・Source:大阪透析研究会会誌(0912-6937)30巻1号 Page43-46(2012.03)
  【新薬展望2012】 (第III部)治療における最近の新薬の位置付け<薬効別> 新薬の広場 消化器癌治療薬(解説/特集) 
・Author:小林佐和子(国立がん研究センター中央病院 肝胆膵腫瘍科), 上野秀樹, 近藤俊輔, 森実千種, 奥坂拓志
・Source:医薬ジャーナル(0287-4741)48巻増刊 Page350-357(2012.01)
タイトル・著者
2011 肝細胞癌に対する内科的局所熱凝固療法の長期予後について
坂口浩樹, 小塚立蔵, 元山宏行, 山口康徳, 中屋美香, 麻植愛, 林健博, 黒岡浩子, 藤井英樹, 小林佐和子, 岩井秀司, 森川浩安, 榎本大, 田守昭博, 河田則文
Journal of Microwave Surgery 29巻 Page123-126(2011.08)
人工胸腹水法を用いたラジオ波焼灼療法 適応と成績
岩井秀司, 松田香奈子, 寺西優雅, 荻原淳司, 遠山まどか, 藤井英樹, 小林佐和子, 森川浩安, 榎本大, 田森昭博, 坂口浩樹, 河田則文
Journal of Microwave Surgery 29巻 Page105-107(2011.08)
  第3回日本肝がん分子標的治療研究会ランチョンセミナー 背景肝からみた肝発癌機構と治療のターゲット
金子周一, 河田則文
The Liver Cancer Journal 3巻1号 Page63-69(2011.03)
B型肝炎 B型肝炎の自然経過
遠山まどか, 榎本大, 田守昭博, 河田則文
日本臨床69巻増刊4 新時代のウイルス性肝炎学 Page335-338(2011.05)
  C型肝炎 C型慢性肝炎に対する治療学の進歩 C型慢性肝炎に対するインターフェロン療法 PEG-IFN・リバビリン併用療法を中心に 我が国におけるPEG-IFN、IFN単独療法の位置づけ
田守昭博, 河田則文
日本臨床69巻増刊4 新時代のウイルス性肝炎学 Page185-189(2011.05)
術前診断に苦慮した肝限局性結節性過形成(FNH)の一例
小林佐和子, 藤井英樹, 岩井秀司, 森川浩安, 榎本大, 田守昭博, 坂口浩樹, 竹村茂一, 久保正二, 河田則文
Source:Modern Physician 31巻2号 Page259-263(2011.02)
B型慢性肝炎に対する核酸アナログ/IFN sequential治療の有用性
榎本大, 田守昭博, 西口修平, 河田則文
消化器内科 52巻1号 Page115-119(2011.01)
肝臓 肝線維化研究の進展
河田則文
Annual Review消化器2011巻 Page175-183(2011.01)
  臨床病理カンファレンス C型肝硬変
岩井秀司, 久保正二, 大澤政彦, 田守昭博, 羽室雅夫, 川村悦史, 伊倉義弘, 森川浩安, 竹村茂一, 河田則文, 上田真喜子
綜合臨床60巻2号 Page309-317(2011.02)
  術前診断に苦慮した肝限局性結節性過形成(FNH)の一例
小林佐和子, 藤井英樹, 岩井秀司, 森川浩安, 榎本大, 田守昭博, 坂口浩樹, 竹村茂一, 久保正二, 河田則文 
Modern Physician(0913-7963)31巻2号 Page259-263(2011.2)
タイトル・著者
2010 【肝・胆道系症候群(第2版) その他の肝・胆道系疾患を含めて】
肝臓編 嚢胞性肝疾患(肝嚢胞、嚢胞肝) 感染性嚢胞肝(解説/特集) 
小林佐和子, 河田則文 日本臨床(0047-1852)別冊肝・胆道系症候群II Page378-380(2010.10)
HBV関連クリオグロブリン血症における抗ホスファチジルセリン・プロトロンビン複合体抗体の意義
榎本大(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 根来伸夫, 藤井英樹, 小林佐和子, 岩井秀司, 森川浩安, 田守昭博, 坂口浩樹, 羽生大記, 塩見進, 河田則文
肝臓(0451-4203)51巻8号 Page454-456(2010.08)
  ソナゾイド造影エコー導入による当科での肝細胞癌局所治療の変化
(原著論文/抄録あり) 
小林佐和子, 山口康徳, 小塚立蔵, 元山宏行, 麻植愛, 林健博, 藤井英樹, 黒岡浩子, 岩井秀司, 榎本大, 森川浩安, 田守昭博, 坂口浩樹, 河田則文 Journal of Microwave Surgery(0917-7728)28巻 Page35-38(2010.08)
【消化器疾患と漢方】 肝・胆・膵疾患と漢方
(解説/特集/抄録あり) 
小林佐和子, 河田則文, 荒川哲男 G.I.Research(0918-9408)18巻4号 Page291-295(2010.08)
【内科疾患の診断基準 病型分類・重症度】 診断メモ 肝腎症候群
榎本大(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田則文
内科(0022-1961)105巻6号 Page1028(2010.06)
【内科疾患の診断基準 病型分類・重症度】 診断メモ 薬物性肝障害
榎本大(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田則文
内科(0022-1961)105巻6号 Page1025(2010.06)
  【内科疾患の診断基準 病型分類・重症度】 肝胆膵 自己免疫性肝炎
小塚立蔵(大阪市立大学 大学院医学研究科肝胆膵病態内科学),
榎本大, 河田則文 
内科(0022-1961)105巻6号 Page986-991(2010.06)
肝細胞癌に対する腹腔鏡的熱凝固療法におけるマイクロ波とラジオ波の違いについて
坂口浩樹、小塚立蔵、元山宏行、山口康徳、中屋美香、麻植 愛、林 健博、黒岡浩子、藤井英樹、小林佐和子、岩井秀司、森川浩安、榎本 大、田守昭博、河田則文
J Microwave Surg 28: 43-46, 2010
  コレシストキニン・パンクレオザイミン(CCK-PZ)
 「広範囲血液・尿化学検査 免疫学的検査(第7版)」

坂口浩樹、岩田康博、小林絢三、荒川哲男
日本臨床68増刊号7: 544-546, 2010
遺伝性肝疾患の腹腔鏡像 「遺伝性肝疾患」
村脇義和監修、向坂彰太郎、孝田雅彦編集
坂口浩樹、小塚立蔵、元山宏行、山口康徳、中屋美香、麻植 愛、林 健博、黒岡浩子、藤井英樹、小林佐和子、岩井秀司、森川浩安、榎本 大、田守昭博、河田則文
中外医学社、東京、2010、13-18s
タイトル・著者
2009 日本肝臓学会コンセンサス神戸2009:C型肝炎の診断と治療
西口修平、泉 並木、日野啓輔、鈴木文孝、熊田博光、伊藤義人、朝比奈靖浩、田守昭博、 平松直樹、林 紀夫、工藤正俊.
肝臓 2009; 50: 665-677.
各種治療に抵抗性を示した自己免疫性肝炎の1例
小塚立蔵(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 岩井秀司, 遠山まどか,藤井英樹, 安田隆弘, 小林佐和子, 黒岡浩子, 中山祐史, 榎本大, 森川浩安, 田守昭博, 坂口浩樹, 河田則文
肝臓(0451-4203)50巻5号 Page223-228(2009.05)
  臨床病理カンファレンス 生活習慣病と非アルコール性脂肪性肝炎(NASH)
久保正二(大阪市立大学 大学院肝胆膵外科学), 大澤政彦, 藤井英樹, 伊倉義弘, 森克仁, 絵本正憲, 上西崇弘, 河田則文, 上田真喜子.
綜合臨床(0371-1900)58巻3号 Page517-525(2009.03)
臨床病理カンファレンス 劇症肝炎
田守昭博(大阪市立大学 大学院肝胆膵病態内科学), 伊倉義弘, 岩井秀司, 天野良亮, 河田則文, 羽室雅夫, 塩見進, 山村仁, 久保正二, 上田真喜子.
綜合臨床(0371-1900)58巻7号 Page1659-1666(2009.07)
タイトル・著者
2008 遡及調査にて判明した輸血後B型肝炎ウイルス感染の1例
田守昭博(大阪市立大学医学部附属病院 輸血部), 藤野惠三, 尾嶋成子,
武田和弘, 河田則文, 日野雅之, 西口修平.
日本輸血細胞治療学会誌(1881-3011)54巻3号 Page393-397(2008.06)
  防風通聖散による薬物性肝障害の1例
元山宏行(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 榎本大, 安田隆弘, 藤井英樹, 小林佐和子, 岩井秀司, 森川浩安, 武田正, 田守昭博, 坂口浩樹, 河田則文.
日本消化器病学会雑誌(0446-6586)105巻8号 Page1234-1239(2008.08)
  原発性肝癌 横隔膜直下の肝癌に対するラジオ波焼灼療法の工夫 
岩井秀司(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 坂口浩樹, 安田隆弘,藤井英樹, 森川浩安, 榎本大, 田守昭博, 河田則文.
Journal of Microwave Surgery(0917-7728)26巻 Page63-65(2008.08)
  原発性肝癌 エンドファイア型超音波腹腔鏡を用いた、
肝細胞癌に対する腹腔鏡的熱凝固療法について

坂口浩樹(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 藤井英樹, 安田隆弘, 小林佐和子, 岩井秀司, 森川浩安, 榎本大, 田守昭博, 河田則文, 関守一.
Journal of Microwave Surgery(0917-7728)26巻 Page85-88(2008.08)
タイトル・著者
2007 GABA含有乳酸菌飲料に起因すると考えられる薬物性肝障害の1例 
河田則文(大阪市立大学 肝胆膵病態内科), 田窪孝行.
内科(0022-1961)99巻1号 Page170-172(2007.01)
  【NASH 最新の知見】 NASHの成因と病態 NASH、酸化ストレスと肝線維化
藤井英樹(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 音川公治, 河田則文.
臨床消化器内科(0911-601X)22巻11号 Page1473-1477(2007.09)
  原発性肝癌 肝細胞癌における熱凝固療法の適応と成績
坂口浩樹(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 安田隆弘, 藤井英樹,黒岡浩子, 小林佐和子, 中山祐史, 岩井秀司, 格谷洋和, 森川浩安, 榎本大, 田守昭博, 武田正,関守一, 河田則文.
Journal of Microwave Surgery(0917-7728)25巻 Page89-91(2007.09)
  原発性肝癌 腹腔鏡下に人工腹水を作製し、経皮的超音波誘導下ラジオ波凝固術を
施行した肝細胞癌の1例

小林佐和子(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 坂口浩樹, 小谷陣,遠山まどか, 安田隆弘, 藤井英樹, 黒岡浩子, 中山祐史, 岩井秀司, 榎本大, 田守昭博, 羽生大記,武田正, 河田則文, 関守一.
Journal of Microwave Surgery(0917-7728)25巻 Page105-108(2007.09)
  難治性自己免疫性肝疾患の病態と新しい治療】 ステロイド抵抗性自己免疫性肝疾患の特徴と対策 アザチオプリン代謝酵素多型を含めて
田守昭博(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田則文, 西口修平.
消化器科(0289-8756)45巻5号 Page525-530(2007.11)
タイトル・著者
2006 日本におけるB型肝炎治療の変遷と工夫
西口修平, 髭修平, 榎本大, 高橋祥一, 高口浩一
Pharma Medica(0289-5803)24巻10号 Page96-105(2006.10)
  原発性肝癌 肝細胞癌における局所熱凝固療法の適応と成績
坂口浩樹(大阪市立大学 大学院肝胆膵病態内科学), 萩原淳司, 遠山まどか, 安田隆弘,藤井英樹, 小林佐和子, 中山祐史, 岩井秀司, 格谷洋和, 榎本大, 田守昭博, 羽生大記, 武田正,河田則文, 関守一.
Journal of Microwave Surgery(0917-7728)24巻 Page87-89(2006.09)
タイトル・著者
2005 肝癌 腹腔鏡下マイクロ波凝固療法の生存率と生存率に寄与する因子について
坂口浩樹(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 萩原淳司, 遠山まどか,安田隆弘, 藤井英樹, 小林佐和子, 中山祐史, 岩井秀司, 格谷洋和, 榎本大, 田守昭博, 羽生大記, 武田正, 河田則文, 関守一.
Journal of Microwave Surgery(0917-7728)23巻 Page31-34(2005.10)
  【B型慢性肝炎の病態別抗ウイルス療法】 ラミブジン中止後の再燃におよぼすラミブジン投与期間とIFN併用の有効性に関する検討
河本まどか(大阪市立大学 医学部肝胆膵病態内科学), 木岡清英, 岡博子, 城村尚登, 榎本大, 田守昭博, 河田則文, 西口修平.
消化器科(0289-8756)41巻6号 Page532-536(2005.12)
  腹腔鏡的局所治療を施行した高齢者肝細胞癌症例の検討
坂口浩樹(大阪市立大学 肝胆膵内科), 萩原淳司, 遠山まどか, 安田隆弘, 藤井英樹,小林佐和子, 中山祐史, 岩井秀司, 格谷洋和, 榎本大, 田守昭博, 羽生大記, 武田正, 河田則文, 関守一, 荒川哲男.
日本高齢消化器医学会議会誌(1345-367X)7巻2号 Page35-39(2005.12)
関連リンク
特記事項
  • 2017年02月06日更新